A mathematical model of prostate tumor growth and androgen-independent relapse

Discrete and Continuous Dynamical Systems - Series B

Volumn 4, Issue 1, 2004, Pages 187-201

  Jackson, T L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Mathematical model; Partial differential equations; Prostate cancer

Indexed keywords

EID: 1042279438     PISSN: 15313492     EISSN: None     Source Type: Journal    
DOI: 10.3934/dcdsb.2004.4.187     Document Type: Conference Paper

References (21)

1. S. Basaria, J. Leib, A.M. Tang, T. DeWeese, M. Carducci, M. Eisenberger and A.S. Dobs, Long-term effects of androgen deprivation therapy in prostate cancer patients, Clin. Endocrin. 56(6) (2002), 779-786.
2. L.T. Baxter and R.K. Jain, Transport of fluid and macromolecules in tumors I: Role of interstitial pressure and convection, Mircovasc. Res. 37 (1989), 77-103.
3. R.R. Berges, J. Vukanovic, J.I. Epstein, M. CarMichel, L. Cisek, D.E. Johnson, R.W. Veltri, P.C. Walsh and J.T. Isaacs, Implication of cell kinetic changes during the progression of human prostatic cancer, Clin. Cancer Res. 1 (1995), 473-480.
4. F. Bladou, R.L. Vessella, K.R. Buhler, W.J. Ellis, L.D. True and P.H. Lange, Cell proliferation and apoptosis during prostatic tumor xenograft involution and re-growth after castration, Int. J. Cancer 67 (1996), 785-790.
5. D. Bray, "Cell Movements," Garland Publishing, New York, 1992.
6. P.K. Burgess, P.M. Kulesa, J.D. Murray and E.C. Alvord, The interaction of growth rates and diffusion coefficients in a three-dimensional mathematical model of gliomas, J. Neuropath. Exp. Neurol. 56 (1997), 704-713
7. H.M Byrne and M.A.J. Chaplain, Modelling the role of cell-cell adhesion in the growth and development of carcinoma, Math. Comput. Model. 24(12) (1996), 1-17.
8. H.B. Carter, J.D. Pearson, E.J. Metter, D.W. Chan, R. Andres, J.L. Fozard, W. Rosner and P.C. Walsh, Longitudinal evaluation of serum androgen levels in men with and without prostate cancer, Prostate 27(1) (1995), 25-31.
9. E.D. Crawford, M. Rosenblum, A.M. Ziada and P.H. Lange Hormone refractory prostate cancer, Urology 54(suppl 6A) (1999), 1-7.
10. L.J, Denis and K. Griffiths, Endocrine treatment in prostate cancer, Semin. Surg. Oncol. 18 (2000), 52-74.
11. 1, Clin. Cancer Res. 2 (1996), 1039-1048.
12. R.T. Greenlee, T. Murray, S. Bolden and P.A. Wingo, Cancer statistics 2000, CA Cancer J. Clin. 50 (2000), 7-33.
13. H.P. Greenspan, On the growth and stability of cell cultures and solid tumors, J. Theor. Biol. 56 (1976) 229-237.
14. C.W. Gregory, R.T. Johnson, S.C. Presnell, J.L. Mohler and F.S. French Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft, J. Androl. 22(4) (2001a) 537-548.
15. C.W. Gregory, B. He, R.T. Johnson , O.H. Ford, J.L. Mohler, F.S. French and E.M. Wilson, A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy, Cancer Res. 61 (11) (2001b), 4315-4319.
16. T. Igawa, F.F. Lin, M.S. Lee, D. Karan, S.K. Batra and M.F. Lin, Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model, Prostate 50(4) (2002), 222-235.
17. T.L. Jackson and H.M. Byrne, A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy, Math Biosci. 164(1) (2000) 17-38.
18. R.K. Jain, Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors, Cancer Res. Suppl. 50 (1990) 814s-819s.
19. + cells of human prostate cancer xenograft LuCaP 23 following castration, Int. J. Cancer 65 (1996), 85-89.
20. C. Palmberg, P. Koivisto, L. Kakkola, T.L.J. Tammela, O.P. Kallioniemi and T. Visakorpi, Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate, J. Urol. 164(6) (2000), 1992-1995.
21. B.I. Rini and E.J. Small, Prostate cancer update, Curr. Opin. Oncol. 14(3) (2002), 286-291.